Acute Cardiovascular Effects of Apelin in Humans
Open Access
- 27 April 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 121 (16), 1818-1827
- https://doi.org/10.1161/circulationaha.109.911339
Abstract
Background— Apelin, the endogenous ligand for the novel G protein–coupled receptor APJ, has major cardiovascular effects in preclinical models. The study objectives were to establish the effects of acute apelin administration on peripheral, cardiac, and systemic hemodynamic variables in healthy volunteers and patients with heart failure. Methods and Results— Eighteen patients with New York Heart Association class II to III chronic heart failure, 6 patients undergoing diagnostic coronary angiography, and 26 healthy volunteers participated in a series of randomized, double-blind, placebo-controlled studies. Measurements of forearm blood flow, coronary blood flow, left ventricular pressure, and cardiac output were made by venous occlusion plethysmography, Doppler flow wire and quantitative coronary angiography, pressure wire, and thoracic bioimpedance, respectively. Intrabrachial infusions of (Pyr 1 )apelin-13, acetylcholine, and sodium nitroprusside caused forearm vasodilatation in patients and control subjects (all P P =0.01) but not apelin ( P =0.3) or sodium nitroprusside ( P =0.9) was attenuated in patients with heart failure. Intracoronary bolus of apelin-36 increased coronary blood flow and the maximum rate of rise in left ventricular pressure and reduced peak and end-diastolic left ventricular pressures (all P 1 )apelin-13 (30 to 300 nmol/min) increased cardiac index and lowered mean arterial pressure and peripheral vascular resistance in patients and healthy control subjects (all P P Conclusions— Acute apelin administration in humans causes peripheral and coronary vasodilatation and increases cardiac output. APJ agonism represents a novel potential therapeutic target for patients with heart failure.Keywords
This publication has 24 references indexed in Scilit:
- Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failureHeart, 2008
- Impaired Heart Contractility in Apelin Gene–Deficient Mice Associated With Aging and Pressure OverloadCirculation Research, 2007
- Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expressionCellular & Molecular Biology Letters, 2007
- Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II–angiotensin type 1 receptor systemJournal of Molecular and Cellular Cardiology, 2006
- Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failureHeart, 2005
- The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivoCardiovascular Research, 2005
- Bradykinin Contributes to the Systemic Hemodynamic Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart FailureArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac ContractilityCirculation Research, 2002
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11Gene, 1993